All In Biotech

Free tool

FAERS Monitor: Abilify Asimtufii

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217006 or its brand name (Abilify Asimtufii, Aripiprazole). Reports on generic versions are filed under their own applications.

Reports

42,627

Serious

36,055

85% of reports

Hospitalization

16,757

Death reported

3,410

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,434
  • off label use2,968
  • product use in unapproved indication2,295
  • drug interaction2,287
  • weight increased2,186
  • anxiety1,806
  • condition aggravated1,714
  • suicide attempt1,584
  • fatigue1,553
  • suicidal ideation1,456
  • toxicity to various agents1,429
  • nausea1,388
  • somnolence1,372
  • sedation1,329
  • schizophrenia1,308

Reports by year received

View as table
YearReports
200468
2005111
2006161
2007217
2008192
2009256
2010342
2011354
2012534
2013428
2014584
20151,211
20161,456
20172,955
20183,363
20193,484
20203,049
20213,704
20223,702
20234,183
20244,341
20254,314
20263,618

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,532 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
schizophreniaSignal1,30859.456.167,006
sedationSignal1,32926.324.930,748
suicide attemptSignal1,58413.212.617,446
suicidal ideationSignal1,4568.07.68,749
drug interactionSignal2,2877.26.912,125
weight increasedSignal2,1864.94.76,692
product use in unapproved indicationSignal2,2954.64.46,484
toxicity to various agentsSignal1,4294.24.03,490
somnolenceSignal1,3723.43.22,301
anxietySignal1,8063.13.02,659
condition aggravatedSignal1,7142.82.71,987
off label use2,9681.71.6838
drug ineffective4,4341.71.61,243
fatigue1,5531.00.90
nausea1,3880.90.830

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.